Miscellaneous (departments of surgery, internal medicine and cardiology)
Conditions
Interventions
The MARCH study is a pre-post intervention study in which a transmural intervention is develloped and implemented, consisting of: a pharmaceutical discharge letter, a post-discharge home visit by a co
Sponsors
1. OLVG: dr. Fatma Karapinar; prof. dr. Patricia van den Bemt; dr. B. van den Bemt and Elien Uitvlugt (PhD candidate) 2. Amsterdam UMC (VUmc): dr. Jacqueline Hugtenburg; prof. dr. E.L. Swart; dr. Pierre Bet and Selma En-nasery – de heer (PhD candidate)
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 years and older, using 5 or more chronic medicines, discharged from the hospital (departments of surgery, internal medicine, cardiology), with 1 or more changes in their chronic medication
Exclusion criteria
Exclusion criteria: Patients discharged to a nursing home, patients with a life expectancy shorter than 6 months, patients with a language barriere, patients not willing or unable due physical/mental constraints to participate in this study, patients' community not enrolled in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of Adverse Drug Events (ADEs) per patient | — |
Secondary
| Measure | Time frame |
|---|---|
| - Number of readmissions within 1 month after discharge - Number and sustainability of medication changes per patient - Number of medication related problems - Health related Quality of Life (EQ-5E-5L) - Patient’s medication satisfaction - Process evaluation to assess the implementation fidelity of the MARCH intervention | — |
Contacts
Public ContactFatma Karapinar
OLVG
Outcome results
None listed